1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Peptide Therapeutics Database

Peptide Therapeutics Database

  • November 2014
  • -
  • La Merie Publishing

Peptide Therapeutics Pipeline Database: 1-Year Subscription


Subscription to La Merie Publishing’s proprietary Peptide Therapeutics Pipeline Database provides online access to Peptide Therapeutics on the market and in research & development. The peptide segment database contains about 900 files.


Each project (file) is specified for its Target or Mechanism of Action, Therapeutic Area and R&D Phase. Use of the R&D database of therapeutic peptides is intuitive. Data sets of interest can be printed and exported in Word or Excel format. Projects are being updated continuously by passive and active searches. Information from press releases is entered on a daily basis. Active searches for targets, indications, company pipelines, scientific congresses, corporate releases, publications and in other sources are conducted on a rotating, regular basis.


The R&D history of each project with online references of information sources can be viewed and printed. The projects can be segmented into Territories, Therapeutic Areas and R&D Phases. A scroll down menu for predefined targets and therapeutic areas (e.g. Anti-Inflammatory Peptides) conveniently selects projects of interest:



  • Anti-Infective Peptides

  • Anti-Inflammatory Peptides

  • Cardiovascular Peptides

  • Cardiometabolic Peptides

  • Cancer Peptides

  • GLP-1 Receptor Agonists (only peptides)

  • PTH Receptor Agonists (only peptides)

  • Peptides Sales in 2013


An advanced search function allows to combine search parameters. By clicking on column heads of the project list, projects can be arranged in ascending or descending alphabetical or numerical order, e.g. for phase, therapeutic area or company name. Sample screenshots illustrate the database.


See our sample screenshots of the database: Download sample screenshots


Prerequisit: Internet access


Purchase of the subscription provides a 1-year online access to the data of the Peptide Therapeutics Pipeline Database. Credentials to access the database will be sent by e-mail within 24 hours after purchase.


Benefits from the Therapeutic Peptide Pipeline Database:



  • Intuitive use

  • 24/7 online access to database via internet

  • Designed for structured searches

  • Focused on targets, therapeutic areas and R&D phases

  • Ideal for competitor analysis (companies, targets, therapeutic areas)

  • Cost-effective and rapid solution for benchmarking

  • Identification of licensing candidates

  • 2013 sales figures of major peptide therapeutics


Project listing in a tabular format:



  • Drug Codes

  • Target / Mechanism of Action

  • Class of Compound

  • Product Category

  • Company

  • Territory

  • Therapeutic Area

  • Indication

  • R&D Phase


Therapeutic Areas:



  • Cardiovascular & blood

  • Dermatology

  • Gastrointestinal

  • Genitourinary, renal & gynecology

  • Infectious & toxicology

  • Metabolism & endocrine

  • Neurology & psychiatry

  • Oncology

  • Ophthalmology & otorhinolaryngology

  • Orthopedics, dental, anesthesia & surgery

  • Pulmonary & respiratory

  • Rheumatoid & autoimmune


Download screenshots

Table Of Contents

Peptide Therapeutics Database

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.